Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
KB408 / Krystal Biotech
Serpentine-1, NCT06049082: A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency	Recruiting	1	12	US	KB408 (Nebulization)	Krystal Biotech, Inc.	Alpha 1-Antitrypsin Deficiency	06/25	05/26